Gilead Sciences Officer Executes 10b5-1 Sale of 3,000 Shares
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📉 Insider Sale: GILD Insider: Mercier Johanna (Chief Comm & Corp Aff Officer) Transaction: Sold 3,000 shares of Common Stock at an average price of ~$144.22 ($432,646.24 total value) Shares Owned Following Transaction: 116,684 shares Filing Date: 2026-09-16 | Trade Date: 2026-09-15 Note: Executed under a pre-established Rule 10b5-1 trading plan.
Comprehensive Analysis
Executive Summary
On September 15, 2026, Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc. (NASDAQ: GILD), sold 3,000 shares of common stock across three tranches at weighted average prices ranging from $143.69 to $145.29, generating total proceeds of approximately $432,646.
Transaction Breakdown
- Tranche 1: 1,600 shares sold at a weighted average price of $143.6917
- Tranche 2: 800 shares sold at a weighted average price of $144.4569
- Tranche 3: 600 shares sold at $145.2900
- Total Shares Sold: 3,000 shares
- Post-Transaction Direct Holdings: 116,684 shares
Plan & Significance Context
- Rule 10b5-1 Trading Plan: The sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 20, 2025.
- Significance Assessment: Low. The disposition represents approximately 2.5% of the insider's total direct equity holdings prior to the transactions, indicating routine, pre-planned portfolio diversification rather than discretionary selling based on material non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.